Natco Pharma
Manufacturing · India · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Natco House Rd No 2 Banjara Hls, Hyderab...Phone Number
+91 4023547532Website
www.natcopharma.co.inRevenue
$506.7 MillionStock Symbol
524816Industry
About Natco Pharma
Natco Pharma Org Chart
Is Natco Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Natco Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Natco Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Natco Pharma
Click to see if Natco Pharma had a recent Job posting/layoffs
Natco Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Natco Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Natco Pharma has new funding data
Check if Natco Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Natco Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Natco Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Natco Pharma.
Natco Pharma Tech Stack
A closer look at the technologies used by Natco Pharma
Natco Pharma News & Media
Natco Pharma Appoints Amit Parekh as Executive VP Finance, Plans CFO Succession
Natco Pharma has appointed Amit Parekh as Executive Vice President-Finance and Accounts, effective December 2, 2025. Parekh is expected to succeed S.V.V.N. Appa Rao as Chief Financial Officer at the Board meeting in February 2026, subject to approvals. This appointment is part of Natco Pharma's succession planning strategy.Natco Pharma's Credit Rating Reaffirmed with Enhanced Limits, Reflecting Strong Financial Profile
ICRA Limited has reaffirmed Natco Pharma's credit ratings at [ICRA]AA (Stable) for long-term and [ICRA]A1+ for short-term instruments. The total rated limits have been significantly increased from Rs. 1,550 crore to Rs. 2,150 crore. This reaffirmation is based on Natco's strong financial performance, healthy margins, and robust debt metrics. The company's revenue increased by 15.92% year-over-year, while EBITDA and net profit both grew by over 35%. Natco's strengths include strong R&D capabilitiNatco Pharma Targets Stake in Adcock Ingram | - Chemical Industry Digest
Natco Pharma to acquire 34.95% of Adcock Ingram for ₹2,000 cr, marking a bold entry into South Africa's fast-growing pharma market.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Natco Pharma
Natco Pharma, founded in 1981 and headquartered in Hyderabad, India, is a pharmaceutical company that makes finished dosage formulations and active pharmaceutical ingredients.... Read More